Macrolide antibiotics promote the LPS-induced upregulation of prostaglandin E receptor EP2 and thus attenuate macrolide suppression of IL-6 production

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 3, 2007, Pages 181-188

  Sato, Yoshinori ^a   Kaneko, Kenichi ^a   Inoue, Matsuhisa ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; CLARITHROMYCIN; CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROLIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG INHIBITION; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE; CLARITHROMYCIN; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROMYCIN; GENE EXPRESSION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOKINES; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 33847648430     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.12.005     Document Type: Article

References (29)

1. Piscitelli S.C., Danziger L.H., and Rodvold K.A. Clarithromycin and azithromycin: new macrolide antibiotics. Clin. Pharm. 11 (1992) 137-152
2. The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. Gut 41 (1997) 8-13
3. Amsden G.W. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?. J. Antimicrob. Chemother. 55 (2005) 10-21
4. Schultz M.J. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J. Antimicrob. Chemother. 54 (2004) 21-28
5. Desaki M., Takizawa H., Ohtoshi T., Kasama T., Kobayashi K., Sunazuka T., Omura S., Yamamoto K., and Ito K. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 267 (2000) 124-128
6. Kikuchi T., Hagiwara K., Honda Y., Gomi K., Kobayashi T., Takahashi H., Tokue Y., Watanabe A., and Nukiwa T. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J. Antimicrob. Chemother. 49 (2002) 745-755
7. Desaki M., Okazaki H., Sunazuka T., Omura S., Yamamoto K., and Takizawa H. Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob. Agents Chemother. 48 (2004) 1581-1585
8. Ianaro A., Ialenti A., Maffia P., Sautebin L., Rombola L., Carnuccio R., Iuvone T., D'Acquisto F., and Di Rosa M. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 292 (2000) 156-163
9. 2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 229-235
10. Vogel S.N., Weedon L.L., Oppenheim J.J., and Rosenstreich D.L. Defective Fc-mediated phagocytosis in C3H/HeJ macrophages. II. Correction by cAMP agonists. J. Immunol. 126 (1981) 441-445
11. 2 inhibition of acute changes in vascular permeability. Inflammation 11 (1987) 279-288
12. 4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem. Biophys. Res. Commun. 278 (2000) 224-228
13. 4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat 74 (2004) 113-123
14. Narumiya S., and FitzGerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108 (2001) 25-30
15. 3 receptor-deficient mice. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3395-3399
16. 4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B. J. Immunol. 177 (2006) 681-693
17. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175 (2005) 3463-3468
18. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 11 (1992) 137-152
19. Lau G.W., Hassett D.J., and Britigan B.E. Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol. 13 (2005) 389-397
20. Zhang G., and Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J. Endotoxin Res. 6 (2000) 453-457
21. 2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 280 (2005) 38969-38975
22. Narumiya S., and FitzGerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108 (2001) 25-30
23. Giroux M., and Descoteaux A. Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J. Immunol. 165 (2000) 3985-3991
24. 4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J. Immunol. 166 (2001) 4689-4696
25. 2: tissue-specific initiation of transcription in the macrophage and the uterus. Biochem. J. 15 (1998) 1115-1121
26. Kondoh K., Hashiba M., and Baba S. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol. Suppl. 525 (1996) 56-60
27. Takizawa H., Desaki M., Ohtoshi T., Kawasaki S., Kohyama T., Sato M., Tanaka M., Kasama T., Kobayashi K., Nakajima J., and Ito K. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156 (1997) 266-271
28. Sakito O., Kadota J., Kohno S., Abe K., Shirai R., and Hara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63 (1996) 42-48
29. 2 and increases lymphocytes in cystic fibrosis lungs. Free Radic. Biol. Med. 39 (2005) 463-472